Koninklijke Philips logo

Koninklijke Philips(OTC) RYLPF

Market Cap$22.81BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+19%
5 Year-44%
1 Year-11%
1 Month-15%
$23.34
+0.00%
+0.00Today
Koninklijke Philips last closing stock price
MetricPriceDate
Last closeUSD 23.342026-10-02
Koninklijke Philips stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.81%USD 25.052026-09-25
1 month-15.37%USD 27.582026-08-31
3 month-16.68%USD 28.012026-07-02
Year to date-7.95%USD 25.362025-12-31
1 year-11.35%USD 26.332025-10-02
3 year+25.76%USD 18.562023-10-03
5 year-43.59%USD 41.372021-10-01
Since inception+18.76%USD 19.652003-07-15

Koninklijke Philips Financials at a Glance

Market Cap

$22.81BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€17.68B

Net Income (TTM)

€1.11B

EPS (TTM)

$1.34

P/E Ratio

17.13

Dividend

$1.00

Beta (Volatility)

0.38 (Low)

Price

$23.34

Volume

151

Open

$23.34

Previous Close

$23.34

Daily Range

$23.34 - $23.34

52-Week Range

$23.34 - $33.00

Estimated Earnings Date

Nov 3, 2026

RYLPF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Koninklijke Philips

Koninklijke Philips N.V. is a leading health technology company with a strong global presence, particularly in North America. The company operates through three main segments: Diagnosis & Treatment, Connected Care, and Personal Health, providing innovative solutions to enhance patient care and improve health outcomes.

Products and Services
  • Advanced diagnostic imaging solutions, including MRI and CT systems
  • Connected care solutions for acute patient management and electronic medical records
  • Personal health products, such as oral hygiene and infant care solutions
Growth Outlook
  • Revenue growth of 11.2% year-over-year in Q2 2026
  • Strong demand for diagnostic imaging and connected care solutions
  • Strategic partnerships enhancing innovation and market reach
Financial Highlights
  • Q2 2026 net income of €384 million, reflecting a 9% net profit margin
  • Trailing twelve months (TTM) revenue of €17.5 billion, with a gross profit margin of 45.9%
  • Dividend yield of 3.8%, indicating a commitment to returning value to shareholders
Koninklijke Philips N.V. has established itself as a key player in the health technology sector, focusing on improving patient outcomes through innovative products and services. The company's diverse offerings in diagnostic imaging, connected care, and personal health cater to a wide range of healthcare needs, positioning it well for future growth. Recent financial performance indicates a robust revenue trajectory, driven by increasing demand for its advanced healthcare solutions. The strategic partnerships with organizations like Ibex Medical Analytics further enhance Philips' capabilities in digital pathology and AI-driven healthcare solutions. With a solid dividend yield and a commitment to innovation, Koninklijke Philips N.V. presents an intriguing opportunity for potential investors interested in the healthcare technology space.
AI Generated • Sep 4, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

63,670

CEO

Roy Jakobs, MBA

Website

www.philips.com/global

Headquarters

Amsterdam, NH 1077 WV, NL

RYLPF Financials

Key Financial Metrics (TTM)

Gross Margin

45.93%

Operating Margin

10.17%

Net Income Margin

6.31%

Return on Equity

10.05%

Return on Capital

8.65%

Return on Assets

4.17%

Earnings Yield

5.84%

Dividend Yield

4.27%

Payout Ratio

31.78%

Stock Overview

Market Cap

$22.81BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

977.43M

Volume

151

Avg. Volume

3.02K

Financials (TTM)

Gross Profit

€8.12B

Operating Income

€1.91B

EBITDA

€3.06B

Operating Cash Flow

€2.28B

Capital Expenditure

-€381.25M

Free Cash Flow

€1.90B

Cash & ST Invst.

€1.79B

Total Debt

€7.47B

Koninklijke Philips Performance Analysis

Koninklijke Philips annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 18,735,719,142-7.6%
20232023-12-31EUR 19,642,789,3914.8%
20242024-12-31EUR 19,493,149,120-0.8%
20252025-12-31EUR 20,127,059,1713.3%
Koninklijke Philips sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-0.8%
Q42025-12-3118.4%
Q12026-03-31-23.1%
Q22026-06-3011.2%
Koninklijke Philips annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR -1.77N/A
20232023-12-31EUR -0.53-70.1%
20242024-12-31EUR -0.9883.8%
20252025-12-31EUR 1.05N/A
Koninklijke Philips sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-24.0%
Q42025-12-31115.8%
Q12026-03-31-61.0%
Q22026-06-30150.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€4.36B

+0.5%

Gross Profit

€2.15B

+6.9%

Gross Margin

49.31%

N/A

Market Cap

$22.81BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$343.57K

N/A

Employees

66,401

N/A

Net Income

€384.00M

+60.0%

EBITDA

€1.02B

+49.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€1.79B

-1.9%

Total Debt

€7.47B

-11.4%

Accounts Receivable

€3.60B

+8.1%

Inventory

€3.22B

-0.5%

Long Term Debt

€6.32B

-12.1%

Short Term Debt

€1.15B

-7.6%

Return on Assets

4.17%

N/A

Return on Invested Capital

9.32%

N/A

Free Cash Flow

€219.00M

-3.9%

Operating Cash Flow

€376.00M

-2.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SDMHFSartorius Stedim Biotech S.A.
$244.00+0.00%
TRUMYTerumo Corporation
$14.21-3.46%
TRUMFTerumo Corporation
$14.06+0.00%
SUVPFSartorius AG
$275.96+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NKENike
$33.87-3.64%
NVDANvidia
$233.95+1.34%
SPCXSpace Exploration Technologies
$158.96+7.36%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$29.71-6.46%

Questions About RYLPF

What is the current price of Koninklijke Philips?

Koninklijke Philips is trading at $23.34 per share.

What is the 52-week range for Koninklijke Philips?

Over the past 52 weeks, Koninklijke Philips has traded between $23.34 and $33.00.

How much debt does Koninklijke Philips have?

As of the most recent reporting period, Koninklijke Philips reported total debt of €8.53B.

How much cash does Koninklijke Philips have on hand?

Koninklijke Philips reported €2.05B in cash and cash equivalents in its most recent financial results.

What is Koninklijke Philips’s dividend yield?

Koninklijke Philips currently has a dividend yield of 4.27%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services